Financial Disclosure

Similar documents
The Albany Consistency Index for the Test of Memory Malingering

The Repeatable Battery for the Assessment of Neuropsychological Status Effort Scale

Performance profiles and cut-off scores on the Memory Assessment Scales

Commentary on Delis and Wetter, Cogniform disorder and cogniform condition: Proposed diagnoses for excessive cognitive symptoms

Comparison of Performance of the Test of Memory Malingering and Word Memory Test in a Criminal Forensic Sample

KEVIN J. BIANCHINI, PH.D., ABPN


Cutoff Scores for MMPI-2 and MMPI-2-RF Cognitive-Somatic Validity Scales for Psychometrically Defined Malingering Groups in a Military Sample

Characterization of the Medical Symptom Validity Test in evaluation of clinically referred memory disorders clinic patients

Background 6/24/2014. Validity Testing in Pediatric Populations. Michael Kirkwood, PhD, ABPP/CN. Conflict of Interest Statement

The unexamined lie is a lie worth fibbing Neuropsychological malingering and the Word Memory Test

Archives of Clinical Neuropsychology Advance Access published April 27, John H. Denning*

Effects of severe depression on TOMM performance among disability-seeking outpatients

Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan

Exaggerated MMPI-2 symptom report in personal injury litigants with malingered neurocognitive deficit

Published online: 25 Aug 2014.

Detection and diagnosis of malingering in electrical injury

International Journal of Forensic Psychology Copyright Volume 1, No. 3 SEPTEMBER 2006 pp. 1-21

AN ESTABLISHMENT OF EMBEDDED SYMPTOM VALIDITY TESTING WITHIN THE DELIS-KAPLAN EXECUTIVE FUNCTIONING SYSTEM. A Dissertation by. Emanuel J.

Improving Accuracy in the. through the use of Technology

Donald A. Davidoff, Ph.D., ABPDC Chief, Neuropsychology Department, McLean Hospital Assistant Professor of Psychology, Harvard Medical School

The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia

ISSN: (Print) (Online) Journal homepage:

Differential diagnosis in the memory clinic: Exploring the value of improved neuropsychological examination Rienstra, A.

A Multi-Method Assessment Approach to the Detection of Malingered Pain: Association with the MMPI-2 Restructured Form

Interpreting change on the WAIS-III/WMS-III in clinical samples

Medical Symptom Validity Test Performance Following Moderate-Severe Traumatic Brain Injury: Expectations Based on Orientation Log Classification

Head injury and the ability to feign neuropsychological deficits

Noncredible Explanations of Noncredible Performance on Symptom Validity Tests

Criterion validity of the California Verbal Learning Test-Second Edition (CVLT-II) after traumatic brain injury

Archives of Clinical Neuropsychology 31 (2016)

Simulated subaverage performance on the Block Span task of the Stanford-Binet Intelligence Scales- Fifth Edition

Optimizing Concussion Recovery: The Role of Education and Expectancy Effects

Chapter 23. Detection of Children s Malingering on Raven s Standard Progressive Matrices*

Financial Disclosure

Published online: 12 Dec 2014.

Ecological Validity of the WMS-III Rarely Missed Index in Personal Injury Litigation. Rael T. Lange. Riverview Hospital.

Base Rates of Impaired Neuropsychological Test Performance Among Healthy Older Adults

Professional Practice Guidelines for the Use and Interpretation of SVTs: The Time Has Come. Jerry Sweet May 20, 2011 London, England

Factors Influencing the Face Validity of Effort Tests: Timing of Warning and Feedback

THE VALIDITY OF THE LETTER MEMORY TEST AS A MEASURE OF MEMORY MALINGERING: ROBUSTNESS TO COACHING. A dissertation presented to.

25 HIGHLIGHTS ON THE USE OF THE MMPI/MMPI- 2 IN A NEUROPSYCHOLOGICAL TEST BATTERY 1

Influence of poor effort on self-reported symptoms and neurocognitive test performance following mild traumatic brain injury

Passing or Failing of Symptom Validity Tests in Academic Accessibility Populations: Neuropsychological Assessment of Near-Pass Patients

Malingering (AADEP Position Paper) The gross volitional exaggeration or fabrication of symptoms/dysfunction for the purpose of obtaining substantial m

10/5/2015. Advances in Pediatric Neuropsychology Test Interpretation Part I: Importance of Considering Normal Variability. Financial Disclosures

The vulnerability to coaching across measures of malingering

NEUROCOGNITIVE VARIABLES UNDERLYING GROUP PERFORMANCE ON A MEASURE OF EFFORT: THE MEDICAL SYMPTOM VALIDITY TEST (MSVT) Julie Hart Covert, M.S.

WPE. WebPsychEmpiricist

Effortless Effort: Current Views on Assessing Malingering litigants in Neuropsychological Assessments

Effects of Coaching on Detecting Feigned Cognitive Impairment with the Category Test

Client/Testing Information

Malingering vs Credibility: A call of caution and robust clinical analysis

Utility of Green s Word Memory Test Free Recall Subtest as a Measure of Verbal Memory: Initial Evidence from a Temporal Lobe Epilepsy Clinical Sample

DETECTION OF MALINGERED MENTAL RETARDATION

Interpretive Report. Client Information

Neuropsychological Testing (NPT)

CLINICAL NEUROPSYCHOLOGY PSYC32

Validation of the Symptoms of Post- Concussion Syndrome Questionnaire as a Self-Report Symptom Validity Test: A Simulation Study. Victoria Jayne Reece

THE EFFICIACY OF THE MMPI-2 LEES- HALEY FAKE BAD SCALE (FBS) FOR DIFFERENTIATING NEUROCOGNITIVE AND PSYCHIATRIC FEIGNERS

Determining causation of traumatic versus preexisting. conditions. David Fisher, Ph.D., ABPP, LP Chairman of the Board PsyBar, LLC

Pain, Malingering, and Performance on the WAIS-III Processing Speed Index

What s Wrong With My Client: Understanding Psychological Testing in Order to Work Effectively With Your Expert

Chapter 2 Malingering: Definitional and Conceptual Ambiguities and Prevalence or Base Rates

Using Neuropsychological Experts. Elizabeth L. Leonard, PhD

Malingering detection in a Spanish population with a known-groups design

Healthy Children Get Low Scores Too: Prevalence of Low Scores on the NEPSY-II in Preschoolers, Children, and Adolescents

VALIDATION OF THE MILLER FORENSIC ASSESSMENT OF SYMPTOMS TEST (M- FAST) IN A CIVIL FORENSIC POPULATION

Potential for interpretation disparities of Halstead Reitan neuropsychological battery performances in a litigating sample,

Comparison of Predicted-difference, Simple-difference, and Premorbid-estimation methodologies for evaluating IQ and memory score discrepancies

Carolyn M. Sherer, M.A.

Elderly Norms for the Hopkins Verbal Learning Test-Revised*

A Dissertation. Submitted to the Faculty. Xavier University. in Partial Fulfillment of the. Requirements for the Degree of. Doctor of Psychology

Agenda. The MMPI-2-RF (Restructured Form) Forensic Practice Briefing. Disclosure

Carmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation

Assessment of Suboptimal Effort Using the CVLT- II Recognition Foils: A Known-Groups Comparison

Differential diagnosis in the memory clinic: Exploring the value of improved neuropsychological examination Rienstra, A.

Utility of the MMPI 2-RF (Restructured Form) Validity Scales in Detecting Malingering in a Criminal Forensic Setting: A Known-Groups Design

Neuropsychology, in press. (Neuropsychology journal home page) American Psychological Association

Executive dysfunction in traumatic brain injury: The effects of injury severity and effort on the Wisconsin Card Sorting Test

Enhancing neuropsychological performance in chronic cannabis users: The role of motivation

THE WORD READING TEST OF EFFORT IN ADULT LEARNING DISABILITY: A SIMULATION STUDY

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy

Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives

Rapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition

Lambros Messinis PhD. Neuropsychology Section, Department of Neurology, University of Patras Medical School

Attention and Memory Dysfunction in Pain Patients While Controlling for Effort on the California Verbal Learning Test-11

Chapter 31 Psychometric Foundations for the Interpretation of Neuropsychological Test Results *

The effect of distraction on the Word Memory Test and Test of Memory Malingering performance in patients with a severe brain injury

Trail making test A 2,3. Memory Logical memory Story A delayed recall 4,5. Rey auditory verbal learning test (RAVLT) 2,6

Discriminant Function Analysis of Malingerers and Neurological Headache Patients Self- Reports of Neuropsychological Symptoms

Use of the Kaufman Brief Intelligence Test - Second Edition as an embedded measure of malingering in a college population

Minimizing Misdiagnosis: Psychometric Criteria for Possible or Probable Memory Impairment

Diagnostic accuracy of the Structured Inventory of Malingered Symptomatology (SIMS) in detecting instructed malingering

Neuropsychology of TBI & PTSD

International Forum on HIV and Rehabilitation Research

University of Kentucky Master's Theses

Qualitative scoring of the Rey 15-Item Memory Test in a forensic population

Method. NeuRA Schizophrenia and bipolar disorder April 2016

Clinical Utility of Wechsler Memory Scale-Revised and Predicted IQ Discrepancies in Closed Head Injury

Transcription:

Historical, Conceptual and Empirical Factors in Performance and Symptom Validity Assessment Glenn J. Larrabee, Ph.D., ABPP Cn Financial Disclosure I have financial relationships to disclose: I receive royalties from Oxford University Press from sales of Assessment of Malingered Neuropsychological Deficits (Larrabee, 2007), and Forensic Neuropsychology: A Scientific Approach (Larrabee, 2012). I receive royalties from Psychological Assessment Resources for sales of the Continuous Visual Memory Test 1

Psychological and Neuropsychological Testing Requires accurate self report on tests such as the MMPI 2 Requires a valid performance on tests of ability, such as the Wechsler Intelligence and Memory scales Since both self report and performance can be controlled by the examinee, it is critical that symptom validity and performance validity is evaluated in each assessment Performance Validity Tests or PVTs PVTs tell you whether the examinee is providing an accurate measure of their actual abilities These can be stand alone like the Test of Memory Malingering (TOMM) or Word Memory Test (WMT) These can be embedded/derived measures based on neurologically atypical patterns or levels of performance on standard tests like the Auditory Verbal Learning Test, Wisconsin Card Sorting Test, Finger Tapping, or Reliable Digit Span. 2

Symptom Validity Tests or SVTs SVTs tell you whether the examinee is providing an accurate report of their actual symptom experience SVTs are included on personality tests like the MMPI 2 RF (Fr, Fp r, Fs, FBS r, RBS) SVTs have also been developed for pain scales such as the Modified Somatic Perception Questionnaire or Pain Disability Index Manfred Greiffenstein 1952-2016 Skeptics approach to forensic neuropsychology Myths of Forensic Neuropsychology Developer of the Reliable Digit Span Studies of MTBI litigants MTBI, PTSD, Chronic Pain and Toxic Exposure MMPI profiles Pre existing profiles Examiner effects FBS and medical conditions Academic records Interests in history & evolutionary psychology 3

PVT Failure Distorts Expected Relationships with Validity Criteria GPA does not show the expected relationship with IQ until those failing PVTs are excluded (Greiffenstein & Baker, 2003) Olfactory identification does not correlate with TBI severity until those failing PVTs are excluded (Green et al., 2003) Memory complaints only correlate with memory performance in those failing PVTs (Gervais et al., 2008) Memory test scores correlate.49 with hippocampal volume in MCIs who pass PVTs, but correlate.11 for those who fail PVTs (Rienstra et al., 2013) PVT Failure Distorts Expected Relationships with Validity Criteria Memory performance does not differ between examinees with and without CT scan abnormalities until those failing PVTs are excluded (Green, 2007) A TBI/neurologically impaired group did not differ on neuropsychological tests from psychiatric, pain or mtbi subjects until those failing PVTs were excluded (Green et al., 2001) Neuropsychological performance was associated with presence/absence of brain injury only in those Ss passing PVTs (Fox, 2011) 4

Frequency of PVT failure in Settings with External Incentive 40% in litigation/compensation seeking mtbi (Larrabee, 2003) 54.3% in criminal defendants (Ardolf et al. 2007) 48.5% in Social Security claimants (Chafetz, 2008) 40% in persons claiming environmental or toxic exposure (Greve et al. 2006) Costs for SSD (SSI and SSDI) in Billions Chafetz & Underhill, 2013 Frequency of PVT Failure Mental Disorders Musculoskeletal Disorder(Chronic Pain) Combined Mental Disorders/Musculo skeletal Disorder 40% $20.022 Billion $14.176 Billion $34.198 Billion 50% $25.028 Billion $17.72 Billion $42.748 Billion 5

Research on SVTs and PVTs In Psychology and Neuropsychology Has Lengthy and Extensive History F scale included in MMPI (1943) Rey (1941) Dot Counting Test Rey (1964) 15 item Test Research on feigned BVRT performance (Benton & Spreen, 1961) Two alternative forced choice testing (Pankratz, Fausti & Peed, 1975) Pattern analysis on standard neuropsychological tests (Heaton, Smith, Lehman & Vogt, 1978) Slick et al. (1999) diagnostic criteria for malingered neurocognitive dysfunction Bianchini et al. (2005) criteria for malingered pain related disability Explosion in PVT and SVT Research 1990 to Present (Sweet & Guidotti Breting, 2013) # pubs with keyword malingering : 1985=1, 1990 = 18, 1995=42, 2000=66, 2005=68, 2010=91, 2011 (1 st 6 months)=60 14 Meta analytic reviews of PVTs and SVTs, 1991 2011 9 edited textbooks: Boone, 2007; Carone & Bush, 2013; Hall & Poirer, 2001; Hom & Denney, 2002; Larrabee, 2007; McCann, 1998; Morgan & Sweet, 2009; Reynolds, 2010; Rogers, 2008 (3 rd ed.) 6

Position Papers from Major Organizations NAN Position Paper, 2005: Symptom exaggeration or fabrication occurs in a sizeable minority of exams, with greater prevalence in forensic contexts; use of PVTs/SVTs maximizes confidence in results and is medically necessary AACN Consensus Statement, 2009: 30 experts; PVT/SVT assessment is important and necessary, particularly in secondary gain contexts, but also in routine clinical practice How are PVTs created? Simulation Design Simulation design usually compares two groups of Ss on the PVT being developed: 1) a group of non injured persons asked to believably feign deficits in an imagined personal injury suit 2) Persons with moderate/severe TBI who do not have external incentive 7

How are PVTs Created? Known Groups or Criterion Groups Design Usually compares two groups on the PVT being studied: 1) a litigating/compensation seeking group of uncomplicated mtbi (normal CT scan, no or brief LOC, limited PTA), who also fail 2 or more PVTs independent of the PVT being studied 2) a group of Ss with moderate/severe TBI who do not have any external incentive Key Difference: PVTs vs. Traditional Test Scores PVTs represent performance that is atypical in pattern or degree compared to performances produced by neurologically, psychiatrically, or developmentally impaired subjects PVTs are criterion referenced Traditional Test scores are norm referenced (compared to the performance of normal [normative] subjects) 8

PVT Survey, Martin et al., 2015, TCN, v. 29, 741 776) Surveyed 316 practicing neuropsychologists, recruited from major professional listserves (e.g. npsych, AACN) Extensive and comprehensive survey This was followed up by an additional survey, of experts alone (Schroeder et al., TCN, 2016, 515 535), n = 24, 12 also in prior study, defined as members of AACN Consensus Group or first author on at least 4 articles/book chapters in past 5 years General Clinician Survey Number of PVTs Used in Forensic Cases Statistic Stand Alone Embedded Total Mean (SD) 2.4 (.97) 3.9 (2.10) 6.3 (2.56) Median 2 4 6 Minimum 0 0 0 Maximum 6 12 16 9

Top 10 Free Standing and Embedded/Derived for Clinicians Free Standing Percent Using Embedded/Derived Percent Using TOMM 77.8 Digit Span 96.2 WMT 58.2 CVLT 2 74.7 MSVT 28.2 Finger Tapping 24.4 Dot Counting 24.7 WCST 24.7 Rey 15 24.1 WMS III/IV 23.1 VSVT 19.3 Rey Figure 17.4 NV MSVT 12.0 RBANS 13.2 ACS WCT 11.1 RAVLT 9.8 btest 9.5 Trail Making 5.7 VIP 4.7 CAT Test 5.4 Top Ten Free Standing and Embedded/Derived Experts Free Standing Percent Using Embedded/Derived Percent Using TOMM 79.2 Digit Span 91.7 WMT 62.5 CVLT 2 54.2 MSVT 41.7 Finger Tapping 37.5 Dot Counting 33.3 WCST 33.3 Rey 15 33.3 WMS III/IV 33.3 VSVT 25.0 RBANS 20.8 b Test 20.8 Trail Making 12.5 NV MSVT 16.7 CPT II 12.5 ACS WCT 16.7 WAIS (exclude D.Sp) 12.5 Rey Word Recog 12.5 Recall v. Recog 12.5 10

Diagnostic Statistics/Terminology Condition of Interest (COI): what is being detected, e.g. invalid performance Sensitivity: the % of Ss detected who actually have the COI Specificity: the % of Ss who are correctly identified who do not have the COI False negative rate: % of Ss with the COI who are not detected False positive rate: the % of Ss without the COI who are incorrectly identified as having the COI Probability of a Diagnosis Referred to as the Positive Predictive Power (PPP) or Positive Predictive Value (PPV) Is broadly defined as Specificity/Specificity + (1 Specificity) Alternatively defined as True Positives/True positives + False Positives PPP is base rate dependent 11

Example of PPP Assume a base rate of 40% (e.g. 40% invalid, 60% valid), and Sensitivity (Sn) of.50 and Specificity (Sp) of.90 With 100 total cases, Sn of.50 identifies 20 cases (.5 x 40), 1 Sp identifies 6 cases (.1 x 60), and PPP is 20/20 + 6 =.79 PVTs, SVTs and Effect of Minimizing the False Positive Rate Use of non litigating patients with moderate and severe TBI, with history of coma and/or CT scan abnormalities, plus a PVT/SVT cutoff with 10% false positive (FP) rate Specifying the characteristics of Ss who are false positive Because of the attempt to minimize false positive error, sensitivity is notably lower PVT meta analysis of Vickery et al. (2001) found mean sensitivity of.56 with mean specificity of.95 Sollman and Berry (2011) found mean sensitivity of.69 with mean specificity of.90 12

PVTs are Easy to Pass for Examinees who have Bona Fide Problems Mean TOMM correct is 98.7% for aphasics Mean TOMM correct is 98.3% for severe TBIs (>1 day up to 3 months of coma); 1 S with GSW, 38 days coma, & right frontal lobectomy scored perfectly (Tombaugh, 1996) 3 patients with bilateral hippocampal damage due to hypoxia passed the PVT trials of the Word Memory Test (Goodrich Hunsaker & Hopkins, 2009) PVTs are Easy to Pass for Examinees who have Bona Fide Problems 94% of Ss with temporal lobe damage (57% left/43% right), intractable epilepsy, & AVLT delay = T39, pass the Effort Index of the AVLT (Silverberg & Barrash, 2005) Performance on 3 PVTs and 1 SVT was not related to presence or absence of CT/MRI lesions or to frontal vs. non frontal location (McBride et al., 2013) 13

PVTs are Easy to Pass in Patients with Bona Fide Problems Cold pressor does not impact performance on Reliable Digit Span or on the TOMM (Etherton, Bianchini, Ciota et al., 2005; Etherton, Bianchini, Greve et al., 2005) Diagnosis Threat does not affect WMT performance (Suhr & Gunstad, 2005) PVTs are Easy to Pass in Patients with Bona Fide Problems Depression (Rees et al., 2001), depression and anxiety (Ashendorf et al., 2004) and depression with chronic pain (Iverson et al., 2007) do not affect TOMM performance 100% of fibromyalgia and rheumatoid arthritis Ss not seeking compensation passed the CARB (Gervais, Russell et al., 2001) 14

% 90 80 70 60 50 40 Trial 1 Trial 2 Retention TBI Sample (N = 45; Tombaugh, 1996) TOMM: TBI 30 20 10 0 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 TOMM Scores % 90 80 70 60 50 40 TOMM: Aphasia Trial 1 Trial 2 Retention Aphasia Sample (N = 21; Tombaugh, 1996) 30 20 10 0 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 TOMM Scores 15

% 90 80 70 60 50 40 TOMM: Dementia Trial 1 Trial 2 Retention Dementia Sample (N = 40; Tombaugh, 1996) 30 20 10 0 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 TOMM Scores The Positive Likelihood Ratio Grimes & Schulz 2005 LR+ is defined as sensitivity/1 specificity LR+ gives likelihood the score came from the group with the condition of interest (COI) as opposed to the group without the COI LR+ multiplied by the base rate odds gives the posttest odds, which can be converted back to a diagnostic probability by the formula odds/odds + 1 16

LR+ for Vickery et al. PVT Meta Analyses Vickery et al. PVT meta analysis, mean Sn = of.56, Sp =.95 For the Vickery et al. PVT meta analysis, LR+ is.56/.05 or 11.2 PPP = base rate odds x LR+ yielding post test odds, which are converted to a probability by odds/odds + 1 Post test odds =.40/.60 (for 40% base rate) or.67 x 11.2 = 7.5; 7.5/8.5 =.88 LR+ for Sollman & Berry PVT Meta Analyses Sollman & Berry PVT meta analysis determined a mean Sn of.69 and Sp of.90 For the Sollman & Berry meta analysis, LR+ is.69/.10 or 6.9 Post test odds =.67 x 6.9 = 4.623 PPP = 4.623/5.623 =.82 17

LR+ for Various Clinical Disorders: Heaton et al., 2004; Center For Evidence Based Medicine, Toronto LR+ for Vickery et al., 11.2 and Sollman & Berry, 6.9 Brain damage vs. no brain damage using AIR from Halstead Reitan (Heaton et al. 2004), LR+ =.771/.146 = 5.28 Alzheimer s positive APOE, LR+ = 2.0 Myocardial Infarction, Cardiac Specific Troponin T, LR+ at 0 2 hours = 6.3 Chronic Obstructive Airway Disease by spirometry, LR+ = 7.3 Slick et al. Criteria for Malingered Neurocognitive Dysfunction Slick, Sherman and Iverson (1999): diagnostic criteria for determination of malingered neurocognitive dysfunction (MND) MND: a) presence of a substantial external incentive, b) evidence from neuropsychological testing and/or self report, and c) evidence from b cannot be primarily accounted for by bona fide neurologic, psychiatric or developmental disorder 18

Slick Criteria Are Probabilistic Significantly worse than chance performance on twoalternative forced choice testing = definite MND, in the presence of substantial external incentive, and absence of rule out conditions In the absence of < chance performance, multiple types of neuropsychological test evidence, or one type of test evidence combined with one pattern of atypical self report, in the presence of external incentive and absence of rule out conditions, can define probable MND Impact of Slick Criteria on Research Subsequent to the appearance of the Slick Criteria in 1999, allowing an operational definition of malingering, there has been a veritable explosion in research on PVTs, SVTs, and malingering One of the early influences was to encourage research on the relationship of multiple independent PVTs to detection of invalid performance/malingering 19

Larrabee (2003, TCN, 17, 410 425) Used up to 31 cases with moderate/severe TBI, and up to 26 cases, primarily mild TBI, without objective radiologic abnormalities who were litigating/compensation seeking, and who performed significantly worse than chance on the PDRT Cutting scores were determined for 4 embedded/derived PVTs (Visual Form Discrimination, Finger Tapping, Reliable Digit Span, WCST FMS) and 1 SVT (MMPI 2 FBS) with the goal of keeping the FP rate for moderate/severe TBI <16%. Identification of Definite MND and Moderate/Severe TBI by Individual PVTs Test and Cutting Score Definite MND identified TBI identified Visual Form Discrimination 12/25 (48%) 27/29 (93.1%) <26 Finger Tapping Combined 10/25 (40%) 29/31 (93.5%) <63 Reliable Digit Span <8 13/26 (50%) 29/31 (93.5%) WCST Failure to Maintain 12/25 (48.0%) 27/31 (87.1%) Set >1 MMPI 2 FBS raw score >21 21/26 (80.8%) 25/29 (86.2%) Average Correctly Identified 53.5% 90.7% 20

Characteristics of False Positive Cases Case 1: Male, in 20s, severe TBI, 1 month coma, 2 months PTA, bilateral CT abnormalities, posttraumatic dementia (FIQ = 75, ID twin = 102). In litigation, Rey 15 = 12, TOMM T2 and Retention = 50, 24 on PDRT easy, 24 on PDRT Hard. RDS = 7, FMS = 2 (both scores just beyond cutoff). Characteristics of False Positive Cases Case 2: Non litigating female in 40s, severe TBI as child, CT shows prior craniotomy and bilateral frontal lobe encephalomalacia. FMS = 3, FBS = 24. Case 3: Litigating female, in 60s, moderate TBI, GCS = 14, CT showed lesion in left internal capsule/lateral thalamus, PTA 3 days, 14 on Rey 15, PDRT Easy = 32 9/9 on Hard, Warrington Words = 39. FMS = 2, FBS = 24. 21

Positive Predictive Power (PPP) Represents the probability of detecting a condition of interest (COI) PPP is defined by relationship of True Positives (TP) and False Positives (FP) PPP = TP / (TP + FP) For the 2 or more out of 5 failure rate PPP = 21/(21 + 3) = 21/24 =.875 For the 3 or more out of 5 failure rate PPP = 13/(13 + 0) = 1.00 Importance of FP rate The preceding slide shows that keeping the FP rate low keeps the PPP high So, low FP rate (high Specificity) is good for ruling in a COI When the false positive rate is zero, only persons with the COI fall in this range 22

Cross Validation Results 15/17 (88.2%) of probable MND, and 100% of neurologic and psychiatric subjects correctly identified by failure of 2 or more PVTs/SVT using the criteria for the definite MND/TBI per test cutoffs 8/17 (47%) of probable MND and 100% of neurologic and psychiatric cases correctly identified by failure of 3 or more PVTs/SVT Comparison of Definite MND and Probable MND Definite MND and Probable MND did not differ on the 5 embedded/derived measures of PVT and SVT Definite MND and Probable MND did not differ on 4 sensitive measures of neuropsychological ability: COWA, Trails B, Verbal Selective Reminding, and CVMT These performance similarities support the definition of probable MND as comprised of multiple PVT and SVT failures (also see Chapter 13, in Larrabee, 2007, Assessment of Malingered Neuropsychological Deficits) 23

Victor et al. (2009, TCN, 23, 297 313) 66 credible patients, who had no external incentive, failed 1 PVT, and did not have dementia or mental retardation 37 non credible patients who had external incentive (litigation, disability claim) and failed at least 2 of 5 PVTs PVTs included Reliable Digit Span, RO Complex Figure Test Effort Equation, RAVLT Effort Equation, and Dominant Hand Finger Tapping Victor et al. Hit Rate, Sensitivity, Specificity PVT Hit Rate Sensitivity Specificity RDS 70.9 43.2 86.4 R O 87.5 81.3 91.7 RAVLT 84.2 86.1 83.1 FTT 69.4 47.1 81.3 Any one test 68.0 94.6 53.0 Any two tests 90.3 83.8 93.9 Any three tests 81.6 51.4 98.5 24

Victor et al. Characteristics of False Positive Cases 30 year old Hispanic female, 8 years education, borderline IQ (77), spoke 10% English while growing up, history of learning disability, bipolar disorder, and substance abuse 17 year old African American male with 10 years education, borderline IQ (72), history of severe TBI with post traumatic seizures, alcohol dependence and learning disability Victor et al. Characteristics of False Positive Cases 53 year old Hispanic male with one year of education in Mexico and borderline IQ (79), English as second language, history of schizophrenia, panic disorder and major depressive disorder 50 year old Caucasian female 14 years education, diagnosed with bipolar disorder and a rule out for somatoform disorder 25

Victor et al False Positive Cases The first 3 Ss described were already on disability, had no other identifiable external incentives to feign, and all failed the same two PVTs: RDS and Finger Tapping The fourth false positive was not on disability, failed 3 embedded PVTs but passed all freestanding PVTs Classification Percentages Victor et al. 2009 and Larrabee, 2003 Value Victor Fail 2/4 PVTs MND = 37 Clinical = 66 Larrabee Fail 2/5 PVT/SVT MND = 41 Clinical = 54 Victor Fail 3 4 PVT MND = 37 Clinical = 66 Larrabee Fail 3/5 PVT/SVT MND = 41 Clinical = 54 Victor Logistic Regress Larrabee Logistic Regress Sensitivity 83.8 87.8 51.4 51.2 85.7 79.2 Specificity 93.9 94.4 98.5 100.0 95.6 85.2 Hit Rate 90.3 91.6 81.6 78.9 91.8 82.4 26

Likelihood Ratios Positive Likelihood Ratio (LR+) LR+ = Sensitivity / (1 Specificity) LR+ = Sensitivity / false positive rate For Preceding Data Victor fail 2 PVTs: LR+ = 83.8 / 6.1 = 13.74 Larrabee fail 2 P/SVTs: LR+ = 87.8 / 5.6 = 15.68 Larrabee (2008, TCN, 22, 666 679) Discussed linking of LR+ as a model of multiple PVT failure, suggesting 2 or more or 3 or more failures provide evidence for probable malingering You can link LR+ if individual PVTs are uncorrelated in the manner of (base rate odds) x LR+ (for 1st failed PVT) x LR+ for second PVT; post test odds are then converted to PPP by odds/odds + 1 Based on Larrabee (2003) actual PPP for each pair wise combination ranged from.800 to 1.00, whereas PPP based on linked LR+ computed for these combinations ranged from.939 to.977 27

Likelihood Ratios and Diagnostic Probability LR+ multiplied by the base rate odds of the COI gives the post test odds of a positive test result Victor fail 2/4 PVTs Base rate = 37/(37 + 66) = 37/103 =.359 Base rate odds =.359/(1.359) =.359/.641 =.56 Given LR+ = 13.74, post test odds = (.56)(13.74) = 7.69 Converting odds to probability (i.e., odds/odds+1), post test probability = 7.69/8.69 =.88 Improving Diagnostic Accuracy by Using Multiple Indicators (Larrabee, 2008) LR+ can be chained, if the individual PVTs and SVTs are independent and either weakly correlated or uncorrelated Consider 2 independent, uncorrelated PVTs, each with a sensitivity of.50 and specificity of.90, and a base rate probability of PVT failure of.40 (yielding base rate odds of.40/1.40 or.67) Post test odds after failing the 1 st PVT are.67 x 5.0 = 3.35, for a post test probability of 3.35/4.35 =.77 The post test odds of 3.35 can now be used to premultiply the LR+ for a 2 nd failed PVT, which also has an LR+ of 5.0, yielding new post test odds of 16.75, for a post test probability of 16.75/17.75 or.94 28

Further Support for Use of Multiple PVTs Boone (2009, TCN, 23, 729 741): you need continuous sampling of PVTs Proto et al. (2014, ACN, 29, 614 624) found reduced neuropsychological performance for mtbi in association with failure of 1 of 6 PVT v. 0 fails, effect sizes, d =.52 ranging to.74 on CVLT, PSI and TMB Proto et al. found linear increase in effect size as a function of number of PVT failures on CVLT 1 5: d = 0.72 for fail 1 v. 0 d = 1.11 for fail 2 v. 0 d = 1.42 for fail 3 v. 0 Statistically Based Criticisms of Use of Multiple PVTs Medici (2013, J of Forensic Psychology Practice, 13, 68 78): the false positive error rate increases with multiple PVTs as per the normal approximation to the binomial Berthelson et al. (2013, Brain Injury, 27, 909 916): Monte Carlo simulation is preferred to the binomial since Monte Carlo allows for PVT intercorrelation while the binomial does not 29

Binomial Equation Example for Failure of 2 PVTs each with a FP rate of.10 Using the Binomial Equation n = total number of items, n1 = subset selected, p =.10, q =.90; to compute probability of failing 2 of 5, this is p for 2/5, + p for 3/5 + p for 5/5 For 2 of 5 indicators: [5!/(2!)(3!)] [(.1 2 )(.9 3 )] or.073 For 3 of 5 indicators: [5!/(3!)(2!)] [(.1 3 )(.9 2 )] or.008 For 4 of 5 indicators: [5!/(4!)(1!)] [(.1 4 )(.9 1 )] or.00045 For 5 of 5:.1 to the 5 th, or essentially zero Thus, for failure 2 of 5 PVTs, each with a.1 FP rate, the combined probability is.073 +.008 +.00045 or.08145 30

Monte Carlo Estimation Crawford et al. (2007, Neuropsychology, 21, 419 430) Requires correlation matrix, R of variables Compute square root of the matrix (the Choleski decomposition) Generate random vector of k independent standard normal variates Post multiply by Choleski decomposition matrix to yield an observation from the desired multivariate normal distribution with a mean vector of 0 and covariance matrix R; repeat preceding steps multiple times This process generates observations with a mean of 0 and SD of 1.0 (the standard normal distribution) Monte Carlo Estimation Continued Berthelson et al. (2013, Brain Injury, 27, 909 916) cite 3 separate investigations showing accurate estimation of actual frequency of failure rates on standard neuropsychological tests Crawford et al. offered caveats to the use of their procedure An important caveat is the assumption of multivariate normality 31

Use of Multiple PVTs Does Not Negatively Impact the Per Test False Positive Rate Berthelson et al. (2013) used Monte Carlo simulation to estimate failure rates for subsets of PVTs failed at either a 10% or 15% per test false positive rate Berthelson et al. found what they interpreted as excessive false positive rates associated with use of multiple PVTs False Positive Percentages for Multiple PVTs at a per test FP Rate of 15% Number of PVTs Used 1 PVTs Failed 2 PVTs Failed 3 PVTs Failed 5 (ACS; Pearson, 22.0 7.0 2.0 2009) 5 (Binomial, Medici, 55.6 16.4 2.6 2013) 5 (Monte Carlo, Berthelson, 2013, r =.31) 45.7 19.4 7.3 4 (Victor et al., 2009) 47.0 6.0 1.0 4 (Binomial) 47.8 11.0 1.2 4 (Monte Carlo) 40.4 14.6 4.3 32

Number of PVTs Used 10% false positive rate 1 PVTs Failed 2 PVTs Failed 3 PVTs Failed 5 (Larrabee, 2014) 42.6 5.6 0.0 5 (ACS, Pearson, 2009) 19.0 5.0 1.0 5 (Binomial, Medici) 40.9 8.1 0.8 5 (Monte Carlo, Berthelson) 33.8 11.5 3.6 7 (Larrabee) 48.1 11.1 3.7 7 (Schroeder & Marshall, Psychotic) 26.0 7.0 0.0 7 (Schroeder & Marshall, non psychotic) 22.0 5.0 0.0 7 (Binomial) 52.2 15.0 2.6 7(Monte Carlo) 41.1 17.5 7.3 Actual PVT Failure Rates in Clinical Patients Contradicts Berthelson et al. Davis and Millis (TCN, 2014, 199 214) found that increasing the number of PVTs administered did not show a significant association with PVT failure Davis and Millis attributed the difference in their findings compared to those of Berthelson et al. to violation of the Monte Carlo assumption of multivariate normality 33

#PVTs administered and # failed is consistent in 3 Samples Davis (from Larrabee & Davis AACN, 2015) Sample N r s Litigants/Disability Claimants 175 -.06 Clinical-VA 863 -.10* Clinical-PM&R 158.13 Clinical-PM&R NNI 87.09 * p =.003 Logistic Regression Models, 1 9 PVTs Predicting MSVT pass/fail (Davis from Larrabee & Davis, 2015, AACN) # PVT Model N AUC SEN SPE %Cor P1 TMA A P1 676.72.23.96 75.4 P2 CVLT FC P1 2 659.78.40.95 79.5 P3 RDS P1 3 612.79.40.94 79.6 P4 FTTD P1 4 496.81.34.95 79.8 P5 WC FMS P1 5 410.82.38.95 81.5 P6 RCF TPR P1 6 194.79.30.97 82.9 P7 LM REC P1 7 110.91.62.96 89.1 P8 VR REC P1 8 109.90.60.97 89.9 P9 VPA REC P1 9 104.93.63.98 91.4 34

Why Monte Carlo Simulated Data do not Match Actual PVT False Positive Rates Berthelson et al. Monte Carlo simulated data creates variables with a mean of 0 and SD of 1 These create simulated data that follow the standard normal curve PVT and SVT data do not follow the normal curve, as they are skewed, with performance commonly at ceiling Examples of Skewed Data From the TOMM Manual 21 aphasic subjects averaged 98.7% correct on Trial 2, with 16 achieving perfect scores 22 severe TBI patients (> 1 day to 3 months of coma) averaged 98.2% correct on Trial 2 with 14 achieving perfect scores These data demonstrate skewed distributions with performances occurring at ceiling, a common finding with PVTs 35

% 90 80 70 60 50 40 Trial 1 Trial 2 Retention TBI Sample (N = 45; Tombaugh, 1996) TOMM: TBI 30 20 10 0 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 TOMM Scores % 90 80 70 60 50 40 TOMM: Aphasia Trial 1 Trial 2 Retention Aphasia Sample (N = 21; Tombaugh, 1996) 30 20 10 0 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 TOMM Scores 36

Larrabee (2008, TCN, 22, 666 679) Presents data on chaining of LR+ If the PVTs are relatively independent, LR+ can be chained, that is, multiplied sequentially Thus, one can chain base rate odds multiplied by PVT 1, PVT 2, etc. In Larrabee (2008) I showed how this chained approach approximated the failure rates for failure of 2 of 5 PVTs/SVT, and 3 of 5 Criticisms of Larrabee (2008) In Larrabee (2008) I pointed out that once one fails 2 or more out of 5 PVTs, linking of new LR+, even for tests falling far below cutoff, would not reduce the post test odds since the value of true positives/false positives would never fall below 1.0, since true positives would always be expected to be greater than false positives Frederick (npsych listserve, 04/15/15) has pointed out that the appropriate use of chaining requires linking of both LR+ and LR 37

Linking of LR+ and LR The procedure still requires pre multiplying by the base rate odds The number of PVTs/SVTs exceeding cutoff identifies the PVT/SVT as contributing to LR+ The number of PVTs/SVTs not exceeding cutoff contributes to LR LR = False Negatives/True Negatives (1 sensitivity/specificity) Frederick s example (npsych, 04/15/15 at 3:35 PM) Example uses a base rate of.4, yielding base rate odds of.4/(1.4) =.667 TOMM TPR =.56, FPR =.02, WMT TPR =.85, FPR =.30, Rey 15 item TPR =.469, FPR =.028, VIP FPR Non Verbal TPR =.662, FPR =.10 For the example of failing the WMT but passing the TOMM, 15 item test, and VIP, the computation is (.667)(.85/.30 WMT)(.44/.98TOMM)(.531/.972 15 Item)(.338/.9VIP) =.174 for post test odds PPP is.174/1.174 =.148 38

Actual Probability of Malingering vs. Probability Determined by Chaining of LR+ and LR Victor et al. (2009), from Table 7, 6% of 66 cases, 4, were FP failing 2, and 84% of 37 cases, 31, were TP failing 2, so PPP = TP/TP + FP or 31/35 =.886; base rate odds =.56 For RDS, LR+ = 3.18, LR =.66, for the Rey Osterrieth, LR+ = 9.80, LR =.20, for the RAVLT, LR+ = 5.09, LR =.17, for FTT, LR+ = 2.52, LR =.65 Chaining of LR+ and LR continued For failure of RDS and Rey O, post test odds are (.56) (3.18)(9.80)(.17)(.65) = 1.93 This value must be added to 5 other computations of pairwise failure to get the post test odds of failing 2 PVTs out of 4, which are 17.74 PPP of failing 2 of 4 is thus 17.74/18.74 or.95, a value higher than the actual PPP of.886 for failure of 2 PVTs 39

Frederick, 2015, Too Much Information: Problems When Using Multiple Malingering Tests This was Frederick s Address for the Distinguished Contributions To Forensic Psychology Award This address provides further examples of linking of likelihood ratios The following example from this address shows problems with the way Frederick chained the likelihood ratios, by not considering all possible combinations of passing vs failing PVTs Frederick 2015 Address Continued Slides 31 33 from this talk provide an example of a case where 7 failed PVTs were chained, using LR+ alone: These included 1)Rey 15 with Recognition, 2)Rey Word, 3)ACS Word Choice Test, 4)Logical Memory II Recognition, 5)Verbal Paired Associates II Recognition, 6)AVLT Logistic Regression, and 7)WCST FMS Frederick demonstrated that by chaining the 7 LR+ associated with the failed PVTs, and the 17 LR associated with the passed PVTs, the posterior probability (at a base rate of.40, base rate odds of.667) was actually quite small, at.0003 40

Frederick s Computations Chaining of the 7 LR+ and 17 LR values yielded a chained LR of.000384456 Multiplying this by.667 yielded a post test odds of.000256432152 This value, divided by 1 + this value, yields a post test probability (rounded off) of.0003 Is the Post Test Probability of.0003 Accurate? If it seems that a p of.0003 for failing 7 PVTs is too low, it is What Frederick computed was the chained LR for failing one particular set of 7 PVTs, and passing one particular set of 17 PVTs Although the computed probability for this one particular set of passed and failed PVTs is accurate, there are 346,104 ways of failing 7 out of 24 PVTs This is easily determined by n!/r!(n r)! Or 24!/7!(24 7)! 41

Implications of Frederick s Computation of the likelihood of Failing 7 and passing 17 PVTs Frederick only analyzed 1 out of 346,104 combinations of 7 out of 24 PVT failures In so doing, he grossly underestimates the probability of failing 7 out of 24 PVTs His example is equivalent to saying: I am going to administer 24 PVTs, but I am only going to conclude invalid performance if the S fails 1)Rey 15 with Recognition, 2)Rey Word, 3)ACS Word Choice Test, 4)Logical Memory II Recognition, 5)Verbal Paired Associates II Recognition, 6)AVLT Logistic Regression, and 7)WCST FMS, but passes the 17 other PVTs The post test odds for 346,103 other combinations of failure of 7 out of 24 PVTs are ignored Putting It All Together Failure of multiple PVTs and SVTs indicates that there is a high probability of invalid data By itself, this indicates that low scores in an evaluation are more likely due to invalid performance, particularly with absence of risk factors for severe impairment such as history of coma Similarly, normal range scores themselves may be low estimates of actual level of ability 42

Putting it All Together PVT and SVT failure alone does not equate to malingering Multiple PVT and SVT failure, in the context of external incentive, with no clear evidence of neurologic, psychiatric or developmental contributions to test performance, meets general criteria for probable malingering (Slick et al., 1999; Bianchini et al. 2005) Below chance on 2 alternative forced choice testing, in the context of external incentive, meets criteria for definite malingering, Pankratz (1990) smoking gun of intent Putting it All Together Larrabee et al 2007 Chapter 13 Definite malingerers (< chance) perform similarly to non injured simulators, establishing < chance as intentional Definite malingerers (< chance) perform similarly to criterion group probable malingerers (multiple PVT/SVT failures), establishing validity of probable malingering criteria as supporting intentionally poor performance Dose effect (Bianchini et al., 2006) showing positive correlation of malingering with increasing external incentive shows that PVT/SVT failure is reinforced by pursuit of external incentives 43

Percentage of Clinical and Malingering Cases Failing PVTs and SVTs Larrabee 2014 # PVT & SVT Failures Clinical Cases n=54 Maling ering Cases n=41 0 1 2 3 4 5 6 7 51.9% 37.0% 7.4% 3.7% 0 0 0 0 0 2.4% 9.8% 24.4% 26.8% 19.5% 17.1% 0 Sensitivity and Specificity for Larrabee 2014 Multiple Indicator Paper PVT/SVT Failure Sensitivity Specificity Likelihood Ratio + 2of 7 97.6 88.9 8.79 3 of 7 87.8 96.3 23.73 4 of 7 63.4 100.0 Cannot compute LR+, however PPP = TP/TP + FP, = 100% 44

Improving Diagnostic Accuracy Results from Controlling per test False Positive rate and use of Multiple PVTs PVT and SVT research focuses on keeping the False+ (FP) rate at 10% or less per test in subjects with significant neurologic, psychiatric and developmental problems Current PVT and SVT research specifies the characteristics of FP cases in derivation studies FP typically occur in Ss who have undeniably severe deficits, often requiring 24 hour supervised care Requirement of multiple PVTs and SVTs improves diagnostic accuracy by reducing False Positive and False Negative rates Summary on PVTs and SVTs The science behind PVTs and SVTs dates back over 70 years, with extensive research in the past 20 years on both stand alone and embedded/derived measures Diagnostic accuracy has focused on keeping the per test false positive rate (FP) at 10% or less which is further enhanced by requiring use of multiple independent PVTs/SVTs PVT/SVT failure is rare in non demented patients; rare in well motivated patients, but frequent (40 50% of the time) in patients having external incentives Costs for mental disorder and pain disability based on invalid data are in the billions of dollars per year 45

Strategies for Analysis of False Positive Cases Determination as to whether an examinee belongs to a patient group at risk for false positive identification (severe TBI, dementia, mental retardation/intellectual disability, schizophrenia with negative symptoms) If an examinee falls in one of these groups, the PVT cutoff can be adjusted (e.g. b Test), or # of failure criterion can be increased (Smith et al., 2014, TCN, 28, 1048 1070) If not in one of these at risk groups, risk of false positive error is reduced Reducing False Positive Error by Combining PVTs or Specifying Minimum Levels of Performance False positive error for single PVTs can be reduced by combining two or more PVTs False positive error for single PVTs can be reduced by specifying minimum levels of performance on actual measures of neuropsychological function 46

Loring et al. RDS and AVLT Recognition in AD, amci and Normal Elderly, ACN, 2016, 313 331 PVT AD, n = 178, age 75.7 False Positive Rate amci, n = 365, age 74.9 False Positive rate Controls, n = 206, age 76.0 False Positive Rate RDS 6 13% 4% 3% AVLT Recognition 70% 42% 9% 9 AVLT Recognition 37% 13% 5% 5 RDS 6 & AVLT 6% 1% 0% Recognition 9 RDS 6 & AVLT 5 4% <1% 0% False Positive Rates As a Function of Minimum Level of Performance on Trails B and AVLT Long Delay Free Recall PVT Total Sample False Positive Rate False Positive Rate for Trails B SS 10 False Positive Rate for AVLT Long Delay Free Recall SS 10 RDS 6 6.1% 2.2% 3.4% AVLT Recognition 39.8% 27% 5.8% 9 47

Normal Performance on Actual Tests Mimicked by PVTs PVTs mimic tests of actual ability RDS mimics working memory, hence performing normally on Arithmetic, Letter Number Sequencing, or AVLT List B shows sufficient native ability to pass RDS The same is true for failure of the TOMM and WMT in the context of normal performance on WMS IV Visual Reproduction, or normal AVLT Performing normally on the Grooved Pegboard test shows adequate motor ability for passing Finger Tapping Summary of Minimizing False Positive Rate Evaluate for clinical condition known to be associated with elevated fp rate (severe neurologic, psychiatric or developmental disorder requiring supervised care) If clinical condition shows fp risk, adjust individual PVT cutoff or # failures required Use multiple PVTs and SVTs that are independent Evaluate domains of actual ability that the PVT mimics; e.g. evidence of normal attention (Arithmetic, Stroop), normal fine motor skills (GPB), normal memory (AVLT) and normal problem solving skills (WAIS BD) shows sufficient native ability to pass RDS, FT, ACS Word Choice Test, and WCST FMS 48

References Ardolf, B. R., Denney, R. L., & Houston, C. M. (2007). Base rates of negative response bias and malingered neurocognitive dysfunction among criminal defendants referred for neuropsychological evaluation. The Clinical Neuropsychologist, 20, 145 159. Ashendorf. L., Constantinou, M., & McCaffrey, R. J. (2004). The effect of depression and anxiety on the TOMM in community dwelling older adults. Archives of Clinical Neuropsychology, 19, 125 130. Benton, A. L., & Spreen, O. (1961). Visual memory test: The simulation of mental incompetence. Archives of General Psychiatry, 4, 79 83. Berthelson, L., Mulchan, S. S., Odland, A. P., Miller, L. J., & Mittenberg, W. (2013). False positive diagnosis of malingering due to the use of multiple effort tests. Brain Injury, 27, 909 916. Bianchini, K. J., Greve, K. W., & Glynn, G. (2005). On the diagnosis of malingered pain related disability: Lessons from cognitive malingering research. Spine Journal, 5, 404 417. References Bush, S. S., Ruff, R. M., Troster, A. I., Barth, J. T., Koffler, S. P., Pliskin, N. H., et al. (2005). Symptom validity assessment: practice issues and medical necessity. NAN policy and planning committee. Archives of Clinical Neuropsychology, 20, 419 426. Carone, D. (2014). Young child with severe brain volume loss easily passes the Word Memory Test and Medical Symptom Validity Test: Implications for mild TBI. The Clinical Neuropsychologist, 28, 146 162. Chafetz, M. (2008). Malingering on the Social Security Disability consultative exam. Predictors and base rates. The Clinical Neuropsychologist, 22, 529 546. Chafetz, M. & Underhill, J. (2013). Estimated costs of malingered disability. Archives of Clinical Neuropsychology, 28, 633 639. Davis, J. J., & Millis, S. R. (2014). Examination of performance validity test failure in relation to number of tests administered. The Clinical Neuropsychologist, 28, 199 214. 49

References Etherton, J. L., Bianchini, K. J., Ciota, M. A., & Greve, K. W. (2005). Reliable Digit is unaffected by laboratory induced pain: Implications for clinical use. Assessment, 12, 101 106. Etherton, J. L., Bianchini, K. J., Greve, K. W., & Ciota, M. A. (2005). Test of Memory Malingering performance is unaffected by laboratory induced pain: Implications for clinical use. Archives of Clinical Neuropsychology, 20, 375 384. Fox, D. D. (2011). Symptom validity test failure indicates invalidity of neuropsychological tests. The Clinical Neuropsychologist, 25, 488 495. Gervais, R. O., Ben Porath, Y. S., Wygant, D. B., & Green, P. (2008). Differential Sensitivity of the Response Bias Scale (RBS) and MMPI 2 validity scales to memory complaints. The Clinical Neuropsychologist, 22, 1061 1079. Gervais, R. O., Russell, A. S., Green, P., Allen, L. M., Ferrari, R., & Pieschl, S. D. (2001). Effort testing in patients with fibromyalgia and disability incentives. The Journal of Rheumatology, 28, 1892 1899. References Goodrich Hunsaker, N. J., & Hopkins, R. O. (2009). Word Memory Test performance in amnesic patients with hippocampal damage. Neuropsychology, 23, 529 534. Green, P. (2007). The pervasive influence of effort on neuropsychological tests. Physical Medicine and Rehabilitation Clinics of North America, 18, 43 68. Green, P., Rohling, M. L., Iverson, G. L., & Gervais, R. O. (2003). Relationships between olfactory discrimination and head injury severity. Brain Injury, 17, 479 496. Greiffenstein, M. F., & Baker, W. J. (2003). Premorbid clues? Preinjury scholastic performance and present neuropsychological functioning in late postconcussion syndrome. The Clinical Neuropsychologist, 17, 561 573. Greve, K. W., Bianchini, K. J., Black, F. W., Heinly, M. T., Love, J. M., Swift, D. A. et al. (2006). The prevalence of cognitive malingering in persons reporting exposure to occupational and environmental substances. NeuroToxicology, 27, 940 950. 50

References Grimes, D. A., & Schulz, K. F. (2005). Epidemiology 3. Refining clinical diagnosis with likelihood ratios. Lancet, 365, 1500 1505. Heaton, R. K., Miller, S. W., Taylor, M. J., & Grant, I. (2004). Revised comprehensive norms for an expanded Halstead Reitan Battery: Demographically adjusted norms for African American and Caucasian adults (HRB). Lutz, FL: Psychological Assessment Resources. Heaton, R. K., Smith, H. H., Jr., Lehman, R. A., & Vogt, A. J. (1978). Prospects for faking believable deficits on neuropsychological testing. Journal of Consulting and Clinical Psychology, 46, 892 900. Heilbronner, R. L., Sweet, J. J., Morgan, J. E., Larrabee, G. J., Millis, S. R., et al. (2009).American Academy of Clinical Neuropsychology consensus conference statement on the neuropsychological assessment of effort, response bias, and malingering. The Clinical Neuropsychologist, 23, 1093 1129. Iverson, G. L., Le Page, J., Koehler, B. E., Shojania, K., & Badii, M. (2007). Test of Memory Malingering (TOMM) scores are not affected by chronic pain or depression in patients with fibromyalgia. The Clinical Neuropsychologist, 21, 532 546. References Larrabee, G. J. (2003). Detection of malingering using atypical performance patterns on standard neuropsychological tests. The Clinical Neuropsychologist, 17, 410 425. Larrabee, G. J. (2007). Introduction. Malingering, research designs and base rates. In G. J. Larrabee (ed.). Assessment of malingered neuropsychological deficits (pp. 3 13). New York: Oxford. Larrabee, G. J. (2008). Aggregation across multiple indicators improves the detection of malingering: Relationship to likelihood ratios. The Clinical Neuropsychologist, 22, 666 679. Larrabee, G.J. (2009). Malingering scales for the Continuous Recognition Memory Test and Continuous Visual Memory Test. The Clinical Neuropsychologist, 23, 167 180. Larrabee, G. J. (2014). False positive rates associated with the use of multiple performance and symptom validity tests. Archives of Clinical Neuropsychology, 29, 364 373. 51

References Larrabee, G. J., Greiffenstein, M. F., Greve, K. W., & Bianchini, K. J. (2007). Refining diagnostic criteria for malingering. In G. J. Larrabee (Ed.). Assessment of malingered neuropsychological deficits (pp. 334 371). New York: Oxford. McBride, W. F., Crighton, A. H., Wygant, D. B., & Granacher, R. P. (2013). It s not all in your head (or at least your brain): Association of traumatic brain lesion presence and location with performance on measures of response bias in forensic evaluation. Behavioral Sciences and the Law, 31, 779 788. Pankratz, L., Fausti, S. A., & Peed, S. A. (1975). A forced choice technique to evaluate deafness in a hysterical or malingering patient. Journal of Consulting and Clinical Psychology, 43, 421 422. Pearson (2009). Advanced clinical solutions for use with WAIS IV and WMS IV. San Antonio: Pearson Education. Rees, L. M., Tombaugh, T. N., & Boulay, L. (2001). Depression and the Test of Memory Malingering. Archives of Clinical Neuropsychology, 16, 501 506. References Rey, A. (1941). L examen psychologique dans le cas d encephalopathie traumatique. Archives de Psychologie, 28, 286 340. Rey, A. (1964). L examen clinique en psychologie [The clinical examination in psychology]. Paris: Presses Universitaires de France. Rienstra, A., Groot, P. F., Spaan, P. E., Majoie, C. B., Nederveen, A. J., Walstra, G. J. et al. (2013). Symptom validity testing in memory clinics: Hippocampal memory associations and relevance for diagnosing mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology, 35, 59 70. Schroeder, R. W., & Marshall, P. S. (2011). Evaluation of the appropriateness of multiple symptom validity indices in psychotic and non psychotic psychiatric populations. The Clinical Neuropsychologist., 25, 437 453. Silverberg, N., & Barrash, J. (2005). Further validation of the expanded Auditory Verbal Learning Test for detecting poor effort and response bias: Date from temporal lobectomy candidates. Journal of Clinical and Experimental Neuropsychology, 27, 907 914. 52

References Slick, D. J., Sherman, E. M. S., & Iverson, G. L. (1999). Diagnostic criteria for malingered neurocognitive dysfunction: Proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13, 545 561. Sollman M. J., & Berry, D. T. R. (2011). Detection of inadequate effort on neuropsychological testing: A meta analytic update and extension. Archives of Clinical Neuropsychology, 26, 774 789. Suhr, J. & Gunstad, J. (2005). Further exploration of the effect of diagnosis threat on cognitive performance in individuals with mild head injury. Journal of the International Neuropsychological Society, 11, 23 29. Sweet, J. J., & Guidotti Breting, L. M. (2013). Symptom validity test research: Status and clinical implications. Journal of Experimental Psychopathology, 4, 6 19. References Tombaugh, T. N. (1996). TOMM. Test of Memory Malingering. New York: Multi Health Systems. Vickery, C. D., Berry, D. T. R., Inman, T. H., Harris, M. J., & Orey, S. A. (2001). Detection of inadequate effort on neuropsychological testing: A meta analytic review of selected procedures. Archives of Clinical Neuropsychology, 16, 45 73. 53